Patent · US Active

Analyte detection system and method for intradermal implantation of biocompatible optode nanosensors

US9974471B1 · kind B1 · utility

33Cited by
9References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 23, 2014
Grant dateMay 22, 2018
Priority date
Expiry dateApr 17, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61B2562/0285
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A device and system for measuring and/or monitoring an analyte present on the skin is provided. The system includes a skin-mountable device that may be attached to an external skin surface and a reader device. The skin-mountable device includes a substrate, a plurality of micro-needles, and nanosensors. The micro-needles are attached to the substrate such that attachment of the substrate to an external skin surface causes to the micro-needles to penetrate into the epidermis, intradermis, or dermis. The nanosensors include a detectable label and are configured to interact with a target analyte present in the interstitial fluid in the epidermis, intradermis, or dermis. The reader device is configured to detect the analyte in interstitial fluid via interaction with the skin-mountable device.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.